LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

<<<<

Select the entities to show:

Small molecules	Cells

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Mean Relative Cell Count	Standard Error of the Mean for Relative Cell Count	Mean Normalized Growth Rate Inhibition Value	Standard Error of the Mean for Normalized Growth Rate Inhibition Value
SK-BR-3	Lapatinib	0.04	uM	LJP6	0.4156	0.0102	0.0194	0.0535
SK-BR-3	Lapatinib	0.12	uM	LJP6	0.4013	0.0208	-0.0065	0.0414
SK-BR-3	Lapatinib	0.37	uM	LJP6	0.3974	0.0125	-0.0149	0.0595
SK-BR-3	Lapatinib	1.11	uM	LJP6	0.4030	0.0158	-0.0045	0.0678
SK-BR-3	Lapatinib	3.33	uM	LJP6	0.4076	0.0076	0.0032	0.0750
SK-BR-3	Lapatinib	10	uM	LJP6	0.4766	0.0259	0.1333	0.0201
SK-BR-3	Sirolimus	0.04	uM	LJP6	0.6708	0.0052	0.4695	0.0399
SK-BR-3	Sirolimus	0.12	uM	LJP6	0.6586	0.0110	0.4489	0.0324
SK-BR-3	Sirolimus	0.37	uM	LJP6	0.6357	0.0202	0.4052	0.0710
SK-BR-3	Sirolimus	1.11	uM	LJP6	0.6255	0.0145	0.3894	0.0522
SK-BR-3	Sirolimus	3.33	uM	LJP6	0.6104	0.0166	0.3657	0.0475
SK-BR-3	Sirolimus	10	uM	LJP6	0.6035	0.0019	0.3530	0.0586
SK-BR-3	ZSTK474	0.04	uM	LJP6	0.8544	0.0439	0.7826	0.0505
SK-BR-3	ZSTK474	0.12	uM	LJP6	0.6589	0.0495	0.4602	0.0349
SK-BR-3	ZSTK474	0.37	uM	LJP6	0.4927	0.0132	0.1609	0.0582
SK-BR-3	ZSTK474	1.11	uM	LJP6	0.4192	0.0065	0.0252	0.0703
SK-BR-3	ZSTK474	3.33	uM	LJP6	0.3927	0.0091	-0.0251	0.0854
SK-BR-3	ZSTK474	10	uM	LJP6	0.3893	0.0127	-0.0310	0.0765
SK-BR-3	BX-912	0.04	uM	LJP5	0.8176	0.0364	0.7237	0.0595
SK-BR-3	BX-912	0.12	uM	LJP5	0.8086	0.0463	0.7192	0.0515
SK-BR-3	BX-912	0.37	uM	LJP5	0.4822	0.0911	0.1747	0.1112
SK-BR-3	BX-912	1.11	uM	LJP5	0.3521	0.0090	-0.0702	0.0459
SK-BR-3	BX-912	3.33	uM	LJP5	0.3669	0.0164	-0.0412	0.0308
SK-BR-3	BX-912	10	uM	LJP5	0.3725	0.0231	-0.0312	0.0513
SK-BR-3	Selumetinib	0.04	uM	LJP6	1.0915	0.0101	1.1386	0.0009